Development & Reproductive Tox (DART)

////Development & Reproductive Tox (DART)
Development & Reproductive Tox (DART) 2013-02-04T11:05:02+00:00

VxP Pharma offers a multi-faceted support program for the evaluation of developmental and reproductive toxicology (DART) studies that involve assessment of both male and female reproductive toxicity.

The support program is designed to investigate the affect of a test article on the following:

  • Fertility and Reproductive Performance
  • Estrous
  • Spermatogenesis
  • Implantation
  • Embryo-fetal survival and development
  • Gestation length
  • Parturition
  • Lactation
  • Pup survival and development
  • Ability of offspring from the exposed parental generation to reproduce normally

Our preclinical team’s experience in protocol design, project management and data interpretation provides a complete range of services designed to include all aspects of developmental and reproductive toxicological studies needed for your program.  We have a very experienced staff available to support all of your DART testing today.

We also offer in-house histo-pathology, as well as in-house hematology to support your program.

At VxP Pharma, we understand your needs and have the extensive experience working with the FDA, USDA, and EPA required to make your animal research projects a success.  Specifically tailored, individual study designs enable our clients to meet their product development goals and facilitate world-wide regulatory approval.  This individualized approach to each study allows us to revise and shift directions based on your changing needs.

The state-of-the-art labs are staffed by some of the best trained and most experienced subject matter experts in the field.

Contact us today for a free consultation with the scientific team and discover how VxP can be a valuable resource and partner for your organization.